Octapharma grants Pfizer US commercialization rights to coagulant
Executive Summary
Octapharma AG (developing human protein products) licensed Pfizer Inc. exclusive rights to market and sell human prothrombin complex concentrate (PCC) in the US.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice